Concentra Biosciences extended its acquisition spree with a buyout deal for struggling Cargo Therapeutics, following purchases of multiple other biotechs facing operational setbacks. Quanterix completed its controversial acquisition of Akoya Biosciences, integrating spatial biology with its diagnostic platforms despite shareholder opposition. These transactions reflect ongoing consolidation and strategic repositioning in the biotech sector amid fluctuating capital markets and shifting investor sentiment.